Webster K Cavenee Selected Research

Histones (Histone)

1/2020	Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM.
12/2019	mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma.
1/2018	Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
12/2017	PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
8/2011	MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Webster K Cavenee Research Topics

Disease

86	Neoplasms (Cancer) 05/2022 - 01/2002
55	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 11/2002
25	Glioma (Gliomas) 12/2019 - 01/2002
16	Brain Neoplasms (Brain Tumor) 12/2019 - 05/2009
7	Melanoma (Melanoma, Malignant) 12/2021 - 08/2010
6	Carcinogenesis 01/2020 - 02/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
3	Leukemia 01/2020 - 03/2013
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 07/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2014 - 02/2007
2	Genomic Instability 08/2011 - 05/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019

Drug/Important Bio-Agent (IBA)

29	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2002
27	epidermal growth factor receptor VIIIIBA 01/2019 - 03/2002
12	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2007
11	Mechanistic Target of Rapamycin Complex 2IBA 01/2020 - 11/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2008
9	Phosphotransferases (Kinase)IBA 10/2013 - 01/2005
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
7	Tyrosine (L-Tyrosine)FDA Link 12/2019 - 12/2011
6	SynteninsIBA 01/2021 - 10/2017
6	LigandsIBA 01/2020 - 01/2002
6	Growth Factor ReceptorsIBA 12/2019 - 01/2005
6	Monoclonal AntibodiesIBA 01/2011 - 03/2002
5	Histones (Histone)IBA 01/2020 - 08/2011
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019 - 09/2006
5	AntibodiesIBA 03/2009 - 01/2002
4	EnzymesIBA 05/2022 - 02/2019
4	Biological ProductsIBA 12/2021 - 05/2013
4	SyndecansIBA 01/2021 - 10/2017
4	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2017
4	TOR Serine-Threonine KinasesIBA 01/2020 - 01/2005
4	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2017 - 02/2005
4	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2011
3	LipidsIBA 05/2022 - 09/2006
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 10/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2019 - 01/2013
3	Sirolimus (Rapamycin)FDA Link 02/2019 - 08/2006
3	CytokinesIBA 01/2019 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 10/2015 - 07/2003
3	monoclonal antibody 806IBA 09/2009 - 03/2002
2	InterleukinsIBA 12/2021 - 01/2019
2	Lysine (L-Lysine)FDA Link 04/2021 - 01/2020
2	IronIBA 12/2019 - 01/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2019 - 07/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2013
2	EpitopesIBA 01/2019 - 01/2006
2	ChromatinIBA 01/2018 - 12/2017
2	TensinsIBA 12/2017 - 08/2012
2	Long Noncoding RNAIBA 10/2017 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 07/2015 - 09/2011
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2013 - 04/2003
2	Epidermal Growth Factor (EGF)IBA 02/2013 - 01/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2012 - 09/2006
2	src-Family KinasesIBA 02/2012 - 09/2009
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 02/2012 - 12/2011
2	Protein Kinases (Protein Kinase)IBA 11/2011 - 05/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2011 - 11/2002
2	PhosphotyrosineIBA 03/2011 - 07/2010
2	Peptides (Polypeptides)IBA 01/2011 - 01/2006
2	Death Domain ReceptorsIBA 03/2007 - 01/2002
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2006 - 11/2005
1	NucleotidesIBA 05/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	IntegrinsIBA 01/2020
1	Lumefantrine FDA Link 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 12/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2019
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 12/2019
1	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Membrane LipidsIBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	NestinIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	CarcinogensIBA 11/2018
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 12/2017
1	Interleukin-13 Receptor alpha2 SubunitIBA 12/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	SurvivinIBA 01/2017
1	Inhibitor of Apoptosis ProteinsIBA 01/2017
1	CaspasesIBA 01/2017
1	Mutant Proteins (Protein, Mutant)IBA 01/2017
1	poly(malic acid)IBA 12/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2016

Therapy/Procedure

41	Therapeutics 12/2021 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 05/2009
3	Radiotherapy 10/2017 - 05/2009
1	Aftercare (After-Treatment) 01/2020
1	Precision Medicine 11/2018
1	Injections 01/2018
1	Oncolytic Virotherapy 01/2017